Like the other Nature titles, Nature Nanotechnology has no external editorial board. Instead, all editorial decisions are made by a dedicated team of professional editors, with relevant research ...

News & Views 12 Feb 2025 Nature Intermediate-affinity CD19-directed CAR T cell product obecabtagene autoleucel demonstrates favourable safety and efficacy in R/R B-ALL Recent data from the FELIX ...